Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 15980953)

Published in Clin Exp Nephrol on June 01, 2005

Authors

Ralf Schiel1, Sebastian Heinrich, Thomas Steiner, Undine Ott, Günter Stein

Author Affiliations

1: Third Department of Internal Medicine, University of Jena Medical School, Jena, Germany. inselklinik.schiel@medigreif.de

Articles cited by this

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract (1995) 12.51

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens (1999) 11.00

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med (1993) 5.61

Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39

Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22

Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol (2002) 2.03

Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial (2003) 1.12

Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation (2003) 1.02

New-onset diabetes after transplantation. J Heart Lung Transplant (2004) 0.89

Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation (2003) 0.85

Type 2 diabetic patients with nephropathy in a Scandinavian kidney-transplant population. Scand J Urol Nephrol (1996) 0.85

A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1998-1999 International Diabetes Federation European Region. Exp Clin Endocrinol Diabetes (1999) 0.83

Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study. Transplantation (2003) 0.83

Death with functioning graft in living donor kidney transplantation: analysis of risk factors. Am J Nephrol (2003) 0.81

Kidney transplantation in type 2 diabetic patients: a comparison with matched non-diabetic subjects. Nephrol Dial Transplant (2002) 0.80

A desktop guide to Type 1 (insulin-dependent) diabetes mellitus. European Diabetes Policy Group 1998. Diabet Med (1999) 0.79

Renal transplantation for type II diabetic patients compared with type I diabetic patients and patients over 50 years old: a single-center experience. Clin Transplant (2000) 0.79

New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial. Acta Diabetol (2004) 0.79

Screening and management of patients with early chronic kidney disease. Acta Diabetol (2004) 0.78

Type II diabetes mellitus and chronic renal insufficiency: renal transplantation or haemodialysis treatment? Nephrol Dial Transplant (1996) 0.77

Increased risk of anemia in dialysis patients with comorbid diseases. Nephrol Nurs J (2004) 0.77

Effects of diabetes and cadaveric organs on functional performance and health-related quality of life after kidney transplantation. Am J Surg (2003) 0.75

Appropriateness and timing of kidney and/or pancreas transplants in type 1 and type 2 diabetes. Adv Ren Replace Ther (2001) 0.75

Kidney and kidney-pancreas transplantation in diabetic recipients. Diabetes Metab (2000) 0.75

Post-transplant diabetes mellitus. J Nephrol (2004) 0.75

Outcome of cadaver kidney transplantation in 23 patients with type 2 diabetes mellitus. Nephrol Dial Transplant (2001) 0.75

Articles by these authors

A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma. J Urol (2011) 1.91

Advanced glycation end products and the kidney. Am J Physiol Renal Physiol (2005) 1.75

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol (2011) 1.72

Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest Ophthalmol Vis Sci (2003) 1.46

Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients. Blood Purif (2012) 1.43

CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol (2005) 1.26

Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol (2003) 1.23

Structures of the Common Cyclodextrins and Their Larger Analogues-Beyond the Doughnut. Chem Rev (1998) 1.20

The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma. Dtsch Arztebl Int (2016) 1.14

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta (2003) 1.01

Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int (2004) 1.01

Open and closed conformation of the E. coli purine nucleoside phosphorylase active center and implications for the catalytic mechanism. J Mol Biol (2002) 0.99

Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats--influence of sex, strain, and surgical procedure. Exp Toxicol Pathol (2005) 0.97

The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Am J Kidney Dis (2006) 0.97

Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int (2005) 0.97

Long-term treatment of obese children and adolescents using a telemedicine support programme. J Telemed Telecare (2008) 0.96

Probing the role of tryptophans in Aequorea victoria green fluorescent proteins with an expanded genetic code. Biol Chem (2004) 0.95

Increased levels of advanced glycation end products in human cataractous lenses. J Cataract Refract Surg (2003) 0.93

A four-subunit cytochrome bc(1) complex complements the respiratory chain of Thermus thermophilus. Biochim Biophys Acta (2005) 0.92

Bone disease after renal transplantation. Nephrol Dial Transplant (2003) 0.92

Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis. Rheumatol Int (2004) 0.92

Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr Nephrol (2002) 0.89

Retinal vessel response to flicker light in children and adolescents with type 1 diabetes mellitus and overweight or obesity. Diabetes Res Clin Pract (2008) 0.88

"Live High-Train Low and High" Hypoxic Training Improves Team-Sport Performance. Med Sci Sports Exerc (2015) 0.87

The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatol Int (2004) 0.86

BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis. Cancer Cell Int (2010) 0.86

Analysis of glycoproteins in human serum by means of glycospecific magnetic bead separation and LC-MALDI-TOF/TOF analysis with automated glycopeptide detection. J Biomol Tech (2007) 0.86

Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7. Proc Natl Acad Sci U S A (2007) 0.84

Comparison of clinical outcome variables in patients with and without etomidate-facilitated anesthesia induction ahead of major cardiac surgery: a retrospective analysis. Crit Care (2014) 0.84

Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension. Nephron Clin Pract (2008) 0.83

The interaction of urinary tract infection and renal insufficiency. Int J Antimicrob Agents (2006) 0.83

Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses. World J Urol (2010) 0.82

Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry). Urology (2006) 0.82

Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus. Nephrol Dial Transplant (2005) 0.82

A neutral molecule in a cation-binding site: specific binding of a PEG-SH to acetylcholinesterase from Torpedo californica. J Mol Biol (2002) 0.82

An autoinhibited state in the structure of Thermotoga maritima NusG. Structure (2013) 0.81

Folate bioavailability from foods rich in folates assessed in a short term human study using stable isotope dilution assays. Food Funct (2014) 0.81

Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int (2002) 0.80

Compound Hub: efficiency gains through innovative sample management processes. Comb Chem High Throughput Screen (2007) 0.80

Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study. Onkologie (2013) 0.80

Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis. J Mol Biol (2004) 0.80

Smelling renal dysfunction via electronic nose. Ann Biomed Eng (2005) 0.79

Recording of dissimulation and denial in the context of the psychosomatic evaluation at living kidney transplantation using the Minnesota Multiphasic Personality Inventory (MMPI). Psychosoc Med (2009) 0.79

Orbital inflammatory pseudotumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patient with atypical, cANCA-positive Wegener's granulomatosis. Rheumatol Int (2003) 0.78

Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial. J Diabetes Complications (2006) 0.78

X-ray crystallographic structures of enamine and amine Schiff bases of pyridoxal and its 1:1 hydrogen-bonded complexes with benzoic acid derivatives: evidence for coupled inter- and intramolecular proton transfer. Acta Crystallogr B (2006) 0.78

Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN). J Diabetes Complications (2003) 0.77

Advanced glycation end-products in corneas of patients with keratoconus. Graefes Arch Clin Exp Ophthalmol (2002) 0.77

Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease. Nephron Clin Pract (2009) 0.77

Advanced glycation end products: a possible link to angiotensin in an animal model. Ann N Y Acad Sci (2005) 0.77

Advanced glycation end-products in anterior chamber aqueous of cataractous patients. J Cataract Refract Surg (2003) 0.77

Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation. World J Urol (2014) 0.76

Fibronectin splice variants--prognostic markers for the stage of renal interstitial fibrosis in the rat. Nephron (2002) 0.76

[Nephrology-part 3: Urinary tract infections]. Med Klin (Munich) (2003) 0.76

Immunochemotherapy-associated protein patterns in tumour tissue and serum of patients with metastatic renal cell carcinoma. Arch Physiol Biochem (2010) 0.76

Another sensitive and safe method to observe lung separation during single-lung ventilation. Anesth Analg (2013) 0.75

How to manage functional vitamin K deficiency in CKD. Am J Kidney Dis (2012) 0.75

Recurrent laryngeal nerve monitoring during esophagectomy and mediastinal lymph node dissection: a novel approach using a single-lumen endotracheal EMG tube and the EZ-blocker. World J Surg (2012) 0.75

Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists. Clin Transplant (2010) 0.75

Anaesthesia and orphan disease: traumatic cardiac arrest in a patient with osteogenesis imperfecta. Eur J Anaesthesiol (2013) 0.75

The prehospital intravenous access assessment: a prospective study on intravenous access failure and access delay in prehospital emergency medicine. Eur J Emerg Med (2016) 0.75

[Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial]. Med Klin (Munich) (2005) 0.75

[Hypersensitivity vasculitis]. Med Klin (Munich) (2003) 0.75

Does it matter who places the intravenous? An inter-professional comparison of prehospital intravenous access difficulties between physicians and paramedics. Eur J Emerg Med (2017) 0.75

Renal interstitial fibrosis (RIF): II. Ultrasound follow up study of single uranyl nitrate administration causing renal dysfunction in rats--comparison with histologic and functional renal parameters. Exp Toxicol Pathol (2002) 0.75

[A rare cause of anemia in a kidney-transplant recipient]. Med Klin (Munich) (2006) 0.75

Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers. Thromb Res (2004) 0.75

[Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation]. Med Klin (Munich) (2009) 0.75

[Nephrology: renal transplantation]. Med Klin (Munich) (2007) 0.75

Validated capillary gas chromatographic-mass spectrometric assay to determine 2-methylcitric acid I and II levels in human serum by using a pulsed splitless injection procedure. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75

[Nephrology--Part 2. Strategies in the immunosuppression after kidney transplantation]. Med Klin (Munich) (2003) 0.75

[A structured treatment and educational program for patients with type 2 diabetes mellitus, insulin therapy and impaired cognitive function (DikoL)]. Med Klin (Munich) (2004) 0.75

Closing the gap between centralized and decentralized compound management approaches. Comb Chem High Throughput Screen (2008) 0.75

Low threshold monocrystalline Nd:(Gd, Lu)2O3 channel waveguide laser. Opt Express (2009) 0.75

[Posttransplantation diabetes mellitus in patients after kidney transplantation - Incidence and risk factors]. Dtsch Med Wochenschr (2016) 0.75

Monocrystalline Yb(3+):(Gd,Lu)(2)O(3) channel waveguide laser at 976.8 nm. Opt Lett (2009) 0.75

[Pregnancy-associated thrombotic microangiopathy--a diagnostic and therapeutic challenge]. Med Klin (Munich) (2002) 0.75

[Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?]. Med Klin (Munich) (2008) 0.75

Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis. Kidney Int (2004) 0.75